Meda, Mylan deal

Generics company Mylan will acquire specialty pharma Meda for SEK165 per share in cash and stock. The deal values Meda at about SEK83.6 billion ($9.9 billion), or SEK60.3 billion ($7.1 billion) net of debt. The price is a 92% premium to Meda’s close of SEK86.05 on Feb. 10, before the deal was announced. ...